BridgeBio Pharma Inc logo

BBIO - BridgeBio Pharma Inc News Story

$48.03 -1.6  -3.1%

Last Trade - 07/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £5.33bn
Enterprise Value £5.60bn
Revenue £6.27m
Position in Universe 1121st / 6854

BRIEF-BridgeBio Pharma and UC Davis Establish Collaboration For Research into Potential Therapies for Genetically Driven Diseases

Tue 13th April, 2021 3:06pm
April 13 (Reuters) - BridgeBio Pharma Inc  BBIO.O :
    * BRIDGEBIO PHARMA, INC. AND UC DAVIS ESTABLISH
COLLABORATION TO
TRANSFORM RESEARCH INTO POTENTIAL THERAPIES FOR GENETICALLY
DRIVEN DISEASES
    * BRIDGEBIO - WILL WORK CLOSELY WITH INVESTIGATORS AT UC
DAVIS TO
SEEK & EVALUATE POTENTIAL RESEARCH PROJECTS IN GENETIC DISEASE &
PRECISION ONCOLOGY

Source text for Eikon:  ID:nGNX4Crd3W 
Further company coverage:  BBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.